- Home
- SNAL vs IOBT Comparison
SNAL vs IOBT Comparison
Compare SNAL & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNAL
- IOBT
- Stock Information
- Founded
- SNAL 2000
- IOBT 2014
- Country
- SNAL United States
- IOBT Denmark
- Employees
- SNAL N/A
- IOBT N/A
- Industry
- SNAL Computer Software: Prepackaged Software
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- SNAL Technology
- IOBT Health Care
- Exchange
- SNAL Nasdaq
- IOBT Nasdaq
- Market Cap
- SNAL 45.1M
- IOBT 50.5M
- IPO Year
- SNAL 2022
- IOBT 2021
- Fundamental
- Price
- SNAL $1.11
- IOBT $0.87
- Analyst Decision
- SNAL
- IOBT Buy
- Analyst Count
- SNAL 0
- IOBT 4
- Target Price
- SNAL N/A
- IOBT $3.50
- AVG Volume (30 Days)
- SNAL 97.1K
- IOBT 7.4M
- Earning Date
- SNAL 11-13-2025
- IOBT 11-07-2025
- Dividend Yield
- SNAL N/A
- IOBT N/A
- EPS Growth
- SNAL N/A
- IOBT N/A
- EPS
- SNAL N/A
- IOBT N/A
- Revenue
- SNAL $91,041,290.00
- IOBT N/A
- Revenue This Year
- SNAL $13.87
- IOBT N/A
- Revenue Next Year
- SNAL $26.20
- IOBT N/A
- P/E Ratio
- SNAL N/A
- IOBT N/A
- Revenue Growth
- SNAL 24.25
- IOBT N/A
- 52 Week Low
- SNAL $0.64
- IOBT $0.32
- 52 Week High
- SNAL $3.42
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- SNAL 52.74
- IOBT 47.19
- Support Level
- SNAL $0.96
- IOBT $0.62
- Resistance Level
- SNAL $1.20
- IOBT $1.23
- Average True Range (ATR)
- SNAL 0.08
- IOBT 0.14
- MACD
- SNAL 0.00
- IOBT 0.06
- Stochastic Oscillator
- SNAL 62.50
- IOBT 47.74
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.